SCHEMBL1370022

SCHEMBL1370022

[CH2]N(C)CCCl

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2597929 0.76
Mechlorethamine SCHEMBL11905424 0.69 MAPT (1.00)
SCHEMBL9813047 0.69
Mechlorethamine SCHEMBL3861 0.69
SCHEMBL131951 0.69
SCHEMBL29262141 0.67
Mechlorethamine SCHEMBL3855 0.67
Mechlorethamine SCHEMBL10618376 0.67 LMNA (1.00)
Mechlorethamine SCHEMBL2554459 0.67
Mechlorethamine SCHEMBL5330778 0.67 LMNA (1.00)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2395997-B1 TREATING INFLAMMATION AND INFLAMMATORY PAIN IN MUCOSA USING MUCOSAL PROLONGED RELEASE BIOADHESIVE THERAPEUTIC CARRIERS. ONXEO S A (FR) 2016-02-10 EP disclosed
US-9192599-B2 Treating inflammation and inflammatory pain in mucosa using mucosal prolonged release bioadhesive therapeutic carriers ONXEO S.A. (FR) 2015-11-24 US disclosed
US-9089559-B2 Treating inflammation and inflammatory pain in mucosa using mucosal prolonged release bioadhesive therapeutic carriers ONXEO S.A. (FR) 2015-07-28 US disclosed
US-20130274306-A1 TREATING INFLAMMATION AND INFLAMMATORY PAIN IN MUCOSA USING MUCOSAL PROLONGED RELEASE BIOADHESIVE THERAPEUTIC CARRIERS Monopar Therapeutics Inc. 2013-10-17 US disclosed
US-20110288140-A1 TREATING INFLAMMATION AND INFLAMMATORY PAIN IN MUCOSA USING MUCOSAL PROLONGED RELEASE BIOADHESIVE THERAPEUTIC CARRIERS BIOALLIANCE PHARMA ,S.A. (FR) 2011-11-24 US disclosed
EP-2368549-A1 Treating hand-foot syndrome and related pathologies using clonidine or its derivatives BioAlliance Pharma (FR) 2011-09-28 EP disclosed
WO-2010031819-A1 TREATING INFLAMMATION AND INFLAMMATORY PAIN IN MUCOSA USING MUCOSAL PROLONGED RELEASE BIOADHESIVE THERAPEUTIC CARRIERS. BIOALLIANCE PHARMA (FR) 2010-03-25 WO disclosed
EP-2165706-A1 Treating Inflammatory Pain in Mucosa of the Oral Cavity Using Mucosal Prolonged Release Bioadhesive Therapeutic Carriers. BioAlliance Pharma (FR) 2010-03-24 EP disclosed